iSERA Lifesciences Ltd

Fri 23/10/2026,11:32:0 | BSE : ISERA

₹143.900.00 (0.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 143.90

Previous Close

₹ 143.90

Volume

1471

Mkt Cap ( ₹ Cr)

₹ 121.01

High

₹ 143.90

Low

₹ 143.90

52 Week High

₹ 151.05

52 Week Low

₹ 7.99

Book Value Per Share

₹ 9.41

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on iSERA Lifesciences Ltd

Your Vote -

Buy

58.33%

Hold

33.33%

Sell

8.33%

58.33%

12 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts iSERA Lifesciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • iSERA Lifesciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    13 Oct 2026, 6:40PM We hereby submit the certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018, for the quarter and half year Y ended

  • iSERA Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended October 01, 2026

    12 Oct 2026, 1:30PM As of October 2026, 55.07% is owned by Indian Promoters and 44.93% by Public. <p align=justify> Top five Promoters holding highest number of shares of

  • iSERA Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    10 Oct 2026, 10:50PM As of September 2026, 58.63% is owned by Indian Promoters and 41.37% by Public. <p align=justify> Top five Promoters holding highest number of shares

  • iSERA Lifesciences - Announcement under Regulation 30 (LODR)-Allotment

    1 Oct 2026, 12:04PM The Board of Directors of the Company, at its meeting held today i.e. October 01, 2026, has approved the allotment of 1,61,82,800 (One Crore Sixty-One

  • iSERA Lifesciences - Board Meeting Outcome for Outcome Of The Board Meeting Of Isera Lifesciences Limited (Formerly Known As

    1 Oct 2026, 12:02PM The Board of Directors of the Company, at its meeting held today i.e. October 01, 2026, has approved the allotment of 1,61,82,800 (One Crore Sixty-One

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Outcome of AGM

    29 Sep 2026, 4:35PM We hereby submit the proceeding of the 34th AGM

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 5:58PM We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known

  • iSERA Lifesciences - Reg. 34 (1) Annual Report.

    5 Sep 2026, 7:30PM we hereby submit Annual Report of Annual General Meeting of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the financ

  • iSERA Lifesciences - Notice Of 34Th Annual General Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technolog

    5 Sep 2026, 7:14PM Notice of 34th Annual General Meeting ('AGM') of the Company is scheduled to be held on Tuesday, September 29, 2026 at 3:00 P.M. (IST) through video c

  • iSERA Lifesciences - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 01.09.2026 Under Regulation 30 Of S

    1 Sep 2026, 4:05PM We hereby informed that Board of Directors of the Company at its meeting held on Tuesday, the 01st September, 2026 discuss the agenda attached herewi

  • iSERA Lifesciences - Submission Of Monitoring Agency Report For Utilization Of Proceeds Of Rights Issue Of Isera Lifesciences

    14 Aug 2026, 10:50PM We hereby submit the monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Tech

  • iSERA Lifesciences - Un-Audited Financial Results For The Quarter Ended June 30, 2026

    7 Aug 2026, 2:49PM We are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.

  • iSERA Lifesciences - Board Meeting Outcome for Outcome Of The Board Meeting Held On 07.08.2026 Under Regulation 30 Of SEBI\r\

    7 Aug 2026, 2:39PM Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure\r\nRequirements), Regulations 2015, the Board of Directors

  • iSERA Lifesciences - Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be H

    3 Aug 2026, 12:32PM Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider a
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of iSERA Lifesciences Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 9.9099 1.5076 -0.0307 0.0088 -0.0045
Liabilities 9.9099 1.5076 -0.0307 0.0088 -0.0045
Equity 8.409 0.3234 0.3234 0.3 0
Gross Profit 0.2662 -0.1262 -0.0988 -0.1163 -0.1055
Net Profit 0.2594 0.139 -0.0988 -0.1117 -0.1055
Cash From Operating Activities -5.3542 -1.4017 -0.0606 -0.1233 -0.3
NPM(%) 19.14 0 0 0 0
Revenue 1.355 0 0 0 0
Expenses 1.0888 0.1262 0.0988 0.1163 0.1055
ROE(%) 3.27 1.75 -1.24 -1.41 -1.33

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to iSERA Lifesciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Prodocs Solutions Ltd 146.00 0.00 9.88 78.43 147.72 0.00
Tata Consultancy Services Ltd 2542.20 1.57 17.93 52091.80 13601.11 4.30
Accelya Solutions India Ltd 962.00 -4.95 15.28 214.80 639.00 0.00
Allied Digital Services Ltd 93.95 -3.94 14.26 813.32 101.71 1.60

Company Info

2012 -Company has changed its name from Lordven Technologies Ltd. to Aptus Industries Ltd. 2013 -M/s. Netocol Systems and Solutions Private Limited - a subsidiary has been amalgamated with Aptus Industries Ltd. (Covidh Technologies Ltd.) 2014 -Mr. UdayChava has been appointed as Executive Vice President of the Company. -Registered Office of the Company has been changed from "501MCR Complex, Sri Swamy Ayyappa Co - Op Housing Society, Madhapur, Hyderabad, Andhra Pradesh - 500081" to "1st Floor, Plot No. 450, Road No. 19, Jubilee Hills, Hyderabad, Andhra Pradesh - 500033." -Company has changed its name from Aptus Industries Ltd to Covidh Technologies Ltd. 2016 -Registered office of the company has changed from Plot No.458, 1st floor, Road No. 19, Jubilee Hills, Hyderabad, Telangana - 500033 to Plot No.458, Ground floor, Road No.19, Jubilee Hills, Hyderabad, Telangana-500033. 2025 -The company issued rights shares of Rs. 10 in the ratio of 25:1 at par.

2012 -Company has changed its name from Lordven Technologies Ltd. to Aptus Industries Ltd. 2013 -M/s. Netocol Systems and Solutions Private Limited - a subsidiary has been amalgamated with Aptus Industries Ltd. (Covidh Technologies Ltd.) 2014 -Mr. UdayChava has been appointed as Executive Vice President of the Company. -Registered Office of the Company has been changed from "501MCR Complex, Sri Swamy Ayyappa Co - Op Housing Society, Madhapur, Hyderabad, Andhra Pradesh - 500081" to "1st Floor, Plot No. 450, Road No. 19, Jubilee Hills, Hyderabad, Andhra Pradesh - 500033." -Company has changed its name from Aptus Industries Ltd to Covidh Technologies Ltd. 2016 -Registered office of the company has changed from Plot No.458, 1st floor, Road No. 19, Jubilee Hills, Hyderabad, Telangana - 500033 to Plot No.458, Ground floor, Road No.19, Jubilee Hills, Hyderabad, Telangana-500033. 2025 -The company issued rights shares of Rs. 10 in the ratio of 25:1 at par.

Parent Organisation

iSERA Lifesciences Ltd.

Founded

27/01/1993

Managing Director

Mrs.Jayshree Suresh Jain

NSE Symbol

FAQ